Corcept Therapeutics | CORT - DÍVIDA





DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Ardelyx USD 208.26M 653K 2026-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
J&J USD 54.99B 7.05B 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Merck USD 49.12B 222M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 47B 14.98B 2026-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
TG Therapeutics USD 754.44M 884K 2026-06